No trading signal from this routine officer role consolidation. Monitor next 10-Q for any material weakness or control change disclosure, but none is expected from this internal move.
Price Chart
Executive Summary
Fulcrum Therapeutics VP of Finance and principal accounting officer Greg Tourangeau mutually agreed to depart, effective August 7, 2026. CFO Alan Musso has been appointed as the new principal accounting officer, effective the same date, receiving no additional compensation. This is a routine internal realignment of accounting officer duties with no financial impact.
Key Facts
- Greg Tourangeau departed as VP of Finance and principal accounting officer on August 7, 2026, per a mutual agreement first disclosed on June 11, 2026.
- Alan Musso, the company's CFO and principal financial officer, was appointed principal accounting officer effective August 7, 2026.
- Musso will receive no additional compensation for the additional role.
Financial Impact
No financial impact — internal reassignment of accounting officer duties with no compensation change.
Risk Factors
- No material risks identified from this routine internal reassignment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-341385 |
| Document: 0001193125-26-341385-index-headers.html | 0001193125-26-341385 |
| Document: 0001193125-26-341385-index.html | 0001193125-26-341385 |
| Document: 0001193125-26-341385.txt | 0001193125-26-341385 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | S-4 | $3.85 $3.70 | ▲ +3.90% | ▲ +3.57% | $3.67 (+4.68%) |
Aug 17, 2026 6w ago | 425 | $3.84 $3.78 | ▲ +1.56% | ▼ −0.42% | $3.67 (+4.43%) |
Aug 17, 2026 6w ago | 425 | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 17, 2026 6w ago | 8-K | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 17, 2026 6w ago | Press Release | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 10, 2026 7w ago | 8-K | $3.75 $3.82 | ▲ +1.87% | ▲ +2.78% | $3.67 (−2.13%) |
Jul 15, 2026 11w ago | 3 | $3.50 $3.71 | ▲ +6.00% | ▲ +2.38% | $3.67 (+4.86%) |
Jun 11, 2026 16w ago | Institutional Cluster | $3.55 $3.59 | ▲ +1.13% | ▼ −0.76% | $3.67 (+3.38%) |
Apr 27, 2026 22w ago | 8-K | $7.72 $6.76 | ▼ −12.44% | ▼ −17.39% | $3.67 (−52.46%) |
Apr 27, 2026 22w ago | Press Release | $7.72 $6.76 | ▼ −12.44% | ▼ −17.39% | $3.67 (−52.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access